ClinVar Miner

Submissions for variant NM_001134407.3(GRIN2A):c.1012A>G (p.Met338Val)

dbSNP: rs1453013171
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Illumina Laboratory Services, Illumina RCV002260550 SCV002540228 uncertain significance Complex neurodevelopmental disorder 2022-02-07 criteria provided, single submitter clinical testing The GRIN2A c.1012A>G (p.Met338Val) missense variant results in the substitution of methionine at amino acid 338 with valine. To our knowledge, this variant has not been reported in the peer-reviewed literature. This variant is not found in version 2.1.1 or version 3.1.2 of the Genome Aggregation Database. Based on the available evidence, the c.1012A>G (p.Met338Val) variant is classified as a variant of uncertain significance for GRIN2A-complex neurodevelopmental disorder.
Labcorp Genetics (formerly Invitae), Labcorp RCV003101439 SCV002948413 uncertain significance Landau-Kleffner syndrome 2024-10-23 criteria provided, single submitter clinical testing This sequence change replaces methionine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 338 of the GRIN2A protein (p.Met338Val). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with GRIN2A-related conditions. This missense change has been observed in at least one individual who was not affected with GRIN2A-related conditions (internal data). ClinVar contains an entry for this variant (Variation ID: 1693282). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed for this missense variant. However, the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on GRIN2A protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
GeneDx RCV004591857 SCV005080339 uncertain significance not provided 2023-12-12 criteria provided, single submitter clinical testing Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.